Cite
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Brief Overview.
MLA
Noel, Zachary R., and Craig J. Beavers. “Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Brief Overview.” American Journal of Medicine, vol. 130, no. 2, Feb. 2017, p. 229.e1-229.e4. EBSCOhost, https://doi.org/10.1016/j.amjmed.2016.09.021.
APA
Noel, Z. R., & Beavers, C. J. (2017). Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Brief Overview. American Journal of Medicine, 130(2), 229.e1-229.e4. https://doi.org/10.1016/j.amjmed.2016.09.021
Chicago
Noel, Zachary R., and Craig J. Beavers. 2017. “Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Brief Overview.” American Journal of Medicine 130 (2): 229.e1-229.e4. doi:10.1016/j.amjmed.2016.09.021.